Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer

Table 5 ORs for gastric non-cardia cancer and peptic ulcer development in IL-2-330 polymorphism

	Genotype	1NUD (n)	Cancer (n)	OR	95% CI	P value	Ulcer (n)	OR	95% CI	P value
IL-2-330	T/T	870	258	-			159	-
	G/T	755	209	0.93	0.76-1.15	0.51	45	0.33	0.23-0.46	< 0.01
	G/G	153	35	0.77	0.52-1.14	0.20	16	0.57	0.33-0.98	0.04
	G carrier	908	244	0.91	0.74-1.11	0.33	61	0.37	0.27-0.50	< 0.01

¹NUD includes gastritis without gastric cancer and peptic ulcer, and atrophic gastritis patients. Because we deleted a number of gastric cardia cancer patients, a number of cancer patients shown in this Table do not match that in Table 1.